Literature DB >> 886222

Studies on plasma vasopressin and the renin-angiotensin-aldosterone system in chronic obstructive lung disease.

M O Farber, S S Kiblawi, R A Strawbridge, G L Robertson, M H Weinberger, F Manfredi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 886222

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  8 in total

Review 1.  Renal and hormonal abnormalities in chronic obstructive pulmonary disease (COPD).

Authors:  P Palange
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

2.  Vasopressin and oxytocin release during prolonged environmental hypoxia in the rat.

Authors:  H Kelestimur; R M Leach; J P Ward; M L Forsling
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

3.  The effects of chronic hypoxia on renal function in the rat.

Authors:  M Neylon; J M Marshall; E J Johns
Journal:  J Physiol       Date:  1997-05-15       Impact factor: 5.182

4.  Comparative effects of angiotensin II on Doppler parameters of left and right heart systolic and diastolic blood flow.

Authors:  B J Lipworth; K D Dagg
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

5.  Effects of angiotensin converting enzyme inhibition on sodium excretion in patients with hypoxaemic chronic obstructive pulmonary disease.

Authors:  A G Stewart; J C Waterhouse; C G Billings; P Baylis; P Howard
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

6.  Hormonal, renal, and autonomic nerve factors involved in the excretion of sodium and water during dynamic salt and water loading in hypoxaemic chronic obstructive pulmonary disease.

Authors:  A G Stewart; J C Waterhouse; C G Billings; P H Baylis; P Howard
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

7.  Mechanism of effect of hypoxia on renal water excretion.

Authors:  R J Anderson; R G Pluss; A S Berns; J T Jackson; P E Arnold; R W Schrier; K E McDonald
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

8.  Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion.

Authors:  S Adnot; P Andrivet; P E Chabrier; J Piquet; P Plas; P Braquet; F Roudot-Thoraval; C Brun-Buisson
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.